Zepp Health (NYSE:ZEPP) Sets New 1-Year High - Still a Buy?

Key Points

• Zepp Health's stock (NYSE:ZEPP) hit a new 52-week high of $35.37 during trading, with the last price recorded at $34.55.
• Despite strong stock performance, the company reported a quarterly EPS of ($1.13) and a revenue of $38.54 million, reflecting a negative net margin of 38.81%.
• Analysts from Fundamental Research issued a "buy" rating with a price objective of $13.87 for Zepp Health, indicating confidence in the company's long-term outlook.

Shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $35.37 and last traded at $34.55, with a volume of 350331 shares trading hands. The stock had previously closed at $31.80.

Wall Street Analysts Forecast Growth

Separately, Fundamental Research set a $13.87 price target on shares of Zepp Health and gave the company a "buy" rating in a report on Tuesday, April 22nd.

Zepp Health Price Performance

The stock's 50 day simple moving average is $9.79 and its 200-day simple moving average is $5.19. The firm has a market cap of $517.76 million, a price-to-earnings ratio of -7.39 and a beta of 1.11. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10.

Zepp Health (NYSE:ZEPP - Get Free Report) last posted its quarterly earnings data on Monday, May 19th. The company reported ($1.13) earnings per share (EPS) for the quarter. The company had revenue of $38.54 million for the quarter. Zepp Health had a negative net margin of 38.81% and a negative return on equity of 24.19%.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.